Jun 23, 2010 | Laboratory News, Laboratory Pathology
Anatomic pathology firm hopes proposed sale of stock will bring in up to $150 million
Anatomic pathology company Aurora Diagnostics, Inc., of Palm Beach Gardens, Florida, just announced a new credit facility that will give it access to as much as $335 million should all conditions be met. Aurora Diagnostics hopes to raise $150 million from an initial public offering (IPO) of its stock, for which it filed registration documents in April.
Aurora Diagnostics was founded in June 2006, by former Ameripath, Inc., executives James New and Marty Stefanelli and was originally funded by Summit Partners and GSO Capital Partners. Over the past four years, Aurora Diagnostics says it has acquired 17 pathology practices. Its revenue for 2009 totaled $171 million, with EBIDTA (earnings before interest, depreciation, taxes, and amortization) of $28 million and net income of $9 million.
(more…)
Feb 17, 2010 | Laboratory News, Laboratory Pathology, News From Dark Daily
February 24 Audio Conference will cover the A-to-Z of Vitamin 25(OH) D Testing
Clinical laboratory testing for Vitamin 25(OH) D continues to the fastest-growing test on the medical laboratory menu, in the United States and other developed nations around the globe. Over the past four years, the steady increase in physician and patient demand for Vitamin D tests has kept most pathology laboratories scrambling to maintain turnaround times and quality.
To help laboratories understand and respond to this unprecedented demand for a simple laboratory test, national Vitamin D expert Bruce Hollis, Ph.D., Director of Pediatric Nutritional Sciences at the Medical University of South Carolina will conduct a special audio conference on February 24 at 1:00 P.M. EST. Pathologists and laboratory professionals will find Dr. Hollis’ session to be an essential and comprehensive explanation of why Vitamin D has become a high profile subject in medicine and how they should position their clinical laboratories to best serve the demand for Vitamin D knowledge and testing.
(more…)
Nov 3, 2009 | Laboratory Management and Operations, Laboratory News, Laboratory Pathology
Peter Built His Company into a Major National Esoteric Laboratory
One of laboratory medicine’s most successful scientist-entrepreneurs died last Friday, October 30, 2009. James B. Peter M.D., Ph.D., Founder of Specialty Laboratories, Inc., died in his home in Santa Monica, California of complications from cancer. He was 76 years old.
A native of Omaha, Nebraska, it was 1958 when Peter earned his M.D. from St. Louis University. He then went to the University of Minnesota where he earned a Ph.D. in Biochemistry in 1963. It was here that he worked with Professor Paul D. Boyer, Ph.D., a laureate for the 1997 Nobel Prize in chemistry. Peter also worked with Boyer at UCLA. At UCLA, Peter served as Professor, Clinical Professor, and College of Letters and Sciences Advisory Board Member. He had a strong interest in clinical chemistry and immunology.
(more…)
Sep 18, 2009 | Laboratory News, Laboratory Pathology
It was The Dark Report’s headline story ten years ago this month!
Introducing a new feature: Ten Years Ago in The Dark Report
To give Dark Daily readers better context about unfolding events in the laboratory industry, we are pleased to introduce this feature which will appear regularly. Each month, we will dive into our archives and share with you the key events of ten years ago, along with an update to those companies and laboratory executives.
American Medical Labs Merges with Associated Pathologists Lab in 1999
In its September 20, 1999 issue, The Dark Report disclosed that Las Vegas-based Associated Pathologists Laboratories (APL) would be merging with American Medical Laboratories (AML) of Chantilly, Virginia. This bi-coastal merger created the third largest commercial laboratory organization in the United States.
(more…)
Aug 21, 2009 | Laboratory Management and Operations, Laboratory News, Management & Operations
It’s the second acquisition of a hospital lab outreach program in past six days
Several days ago, a two-part deal was announced between Quest Diagnostics Incorporated (NYSE:DGX) and Caritas Christi Health Care of Boston, Massachusetts. Caritas sold its clinical laboratory outreach business to Quest Diagnostics and both parties formed a “strategic alliance” going forward that centers upon laboratory testing and informatics integration. Caritas will continue to own and manage the laboratories in its six hospitals.
This is the second sale of a hospital laboratory outreach business in the past two weeks. On August 12, Sonic Healthcare (SYD:SHL) acquired Piedmont Medical Laboratories (PML) of Winchester, Virginia. PML was owned by Valley Health, an eight-hospital health system. (See Dark Daily, ‘Sonic Healthcare’s Latest Lab Buying Spree Nets Two U.S. Labs for $20 Million”, August 13, 2009.)
(more…)
